Efficacy and Safety of Medication for Attention-Deficit Hyperactivity Disorder in Children and Adolescents with Common Comorbidities: A Systematic Review.
Noa TsujiiMasahide UsamiNoriyuki NayaToshinaga TsujiHirokazu MishimaJunko HorieMasakazu FujiwaraJunzo IidaPublished in: Neurology and therapy (2021)
Limited information is available from placebo-controlled RCTs on the efficacy (by ADHD-RS-IV) or safety of medication in children with ADHD and psychiatric comorbidities. Further studies are required to support evidence-based drug selection for these populations.
Keyphrases
- attention deficit hyperactivity disorder
- adverse drug
- autism spectrum disorder
- placebo controlled
- working memory
- healthcare
- double blind
- young adults
- mental health
- study protocol
- clinical trial
- case control
- phase ii
- squamous cell carcinoma
- randomized controlled trial
- emergency department
- electronic health record
- phase iii
- open label